Starpharma Holdings reports positve results from VivaGel® clinical trial - Proactive Investors Australia
Posted by admin / Under Bacterial Vaginosis![]() Proactive Investors Australia | Starpharma Holdings reports positve results from VivaGel® clinical trial Proactive Investors Australia Starpharma plans to commence further clinical studies of VivaGel®, including a phase 2 efficacy study in bacterial vaginosis, during 2010. ... |
Published on Friday 12th of March 2010 01:25:16 AM
Read more...
Published on Friday 12th of March 2010 01:25:16 AM
Read more...




